Session Details

Genetic Polymorphism and Regulation of Gene Expression Posters

Tuesday, 23 March 2004 17:20 -18:30

Urokinase Plasminogen Activator Promotes Unfavorable Vessel Remodeling and Changes the Expression of Oxidation Related Genes in Balloon-injured Rat Carotid Artery
  • Prof Yelena V Parfyonova, Cardiology Research Center of Russia, Russia
  • Post-transcriptional Regulation of Prothrombin Gene Expression and the G20210A Polymorphism
  • Mythily Sachchithananthan, Monash University, Australia
  • The Improved Translation of Human Tissue-type Plasminogen Activator Gene in E. coli
  • Young-Doug Sohn, Cardiovascular Res Inst and BK21 Projects for Medical Sciences, Korea
  • Differential Gene Expression Response in Human Endothelium Exposed to Shear Stress or Pressure Stimulation
  • Maria Andersson, Clinical Experimental Research Laboratory, Cardiovascular Institute, Sweden
  • C/EBPβ Regulates Plasminogen Gene Expression in Response to Interleukin 6 (IL-6)
  • Dr Lindsey A Miles, The Scripps Research Institute, United States
  • Calpain Prevents p53-dependent Apoptosis of Vascular Smooth Muscle Cells Exposed to Mechanic Overload
  • Daniel Sedding, Internal Medicine I - Cardiology - University of Giessen, Germany
  • The PAI-2 Regulated Gene Expression Profile in Human Monocyte THP-1 Cells
  • Dr Hong Yu, Monash University, Box Hill Hospital, Australia
  • Post-Transcriptional Regulation of Plasminogen Activator Inhibitor Type 2 Gene Expression
  • Dr Stan J Stasinopoulos, Monash University, Australia
  • Prevalence of Common Genetic Polymorphisms in Consecutive Patients with Thrombophilia from Oman
  • Dr Devendra Hiwase, Sultan Qaboos University Hospital, Australia
  • Plasminogen Activator Inhibitor Type 1 (PAI-1) Polymorphisms and Recurrent Miscarriage Syndrome
  • Rodger L Bick, Univ. Texas Southwestern Medical Center, United States
  • Thrombotic Events and Repeated Fetal Loss in Pai-1 4g/4g Homozygous Persons
  • Prof Miroslav Penka, Czech Republic
  • Genetic Testing for Common Genetic Thrombosis Risk Factors (Factor V Leiden, Factor II G20210A, MTHFR C677T) in Retinal Vascular Occlusive Disease
  • Dr Katalin Várnai, Hospital of the National Railways (MÁV), Hungary